YP
DGX icon

YANKCOM Partnership’s Quest Diagnostics DGX Stock Holding History

YANKCOM Partnership’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Buy
6,383
+184
+3% +$36.1K 0.49% 44
2026
Q1 		$1.21M Sell
6,199
-47
-0.8% -$9.13K 0.5% 50
2025
Q4 		$1.08M Buy
6,246
+20
+0.3% +$3.64K 0.46% 56
2025
Q3 		$1.19M Sell
6,226
-731
-11% -$130K 0.53% 49
2025
Q2 		$1.25M Buy
6,957
+14
+0.2% +$2.43K 0.61% 41
2025
Q1 		$1.17M Sell
6,943
-120
-2% -$19.7K 0.65% 41
2024
Q4 		$1.07M Buy
+7,063
New +$1.1M 0.57% 48

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

YANKCOM Partnership's DGX Position: Q2 2026 in Review

YANKCOM Partnership increased its Quest Diagnostics (DGX) stake by 3% in Q2 2026, buying an estimated $36.1K and bringing the position to 6,383 shares worth $1.35M. The position accounts for 0.49% of the portfolio, ranked #44.

YANKCOM Partnership first reported a position in DGX in Q4 2024 and has held it in 7 quarters since. 604 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • YANKCOM Partnership held 6,383 shares of Quest Diagnostics worth $1.35M as of Q2 2026.
  • YANKCOM Partnership bought 184 Quest Diagnostics shares in Q2 2026, an estimated $36.1K.
  • Quest Diagnostics made up 0.49% of YANKCOM Partnership's portfolio in Q2 2026, its #44 holding.
  • YANKCOM Partnership first reported a position in Quest Diagnostics in Q4 2024 and has held it in 7 quarters since.
  • 604 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on YANKCOM Partnership's 13F filing for Q2 2026, filed 21 Jul 2026.